Related Experiment Video
Updated: Jul 31, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Targeting neuronal nitric oxide synthase with gene transfer to modulate cardiac autonomic function
R M Mohan1, S Golding, D A Heaton
1University Laboratory of Physiology, University of Oxford, Parks Road, Oxford OX1 3PT, UK.
Progress in Biophysics and Molecular Biology
|February 11, 2004
Summary
Gene transfer using adenovirus-nNOS enhances cardiac vagal responsiveness and reduces beta-adrenergic excitability. This approach shows promise for treating cardiac autonomic dysfunction by restoring physiological function.
Area of Science:
- Cardiovascular Physiology
- Neuroscience
- Molecular Biology
Background:
- Neuronal nitric oxide synthase (nNOS) microdomains are critical in cardiac autonomic neurons and myocytes.
- Understanding nNOS's role in cardiac autonomic control is essential for therapeutic development.
Purpose of the Study:
- To review gene transfer strategies for investigating nNOS in cardiac autonomic control.
- To explore improved gene delivery techniques for cardiac autonomic nervous system targets.
- To assess the functional impact of adenovirus-mediated nNOS gene transfer.
Main Methods:
- Utilized adenoviral vectors for gene delivery to cardiac-neural tissue.
- Investigated the effects of adenovirus-nNOS on cardiac autonomic function.
- Examined potential modifications for viral vector tropism and alternative gene delivery mechanisms.
Main Results:
- Adenoviral vectors demonstrated efficient gene delivery to cardiac-neural tissue.
- Adenovirus-nNOS increased cardiac vagal responsiveness via enhanced cholinergic neurotransmission.
- Adenovirus-nNOS decreased beta-adrenergic excitability.
Conclusions:
- Gene transfer, particularly with adenoviral vectors, is an effective method for modulating cardiac autonomic function.
- Future strategies require site-specific promoters for sustained gene expression and physiological restoration.
- This approach holds potential for targeting cardiac autonomic impairment.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...